Active, not recruitingPhase 2NCT02179086
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Studying Giant cell glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NRG Oncology
- Principal Investigator
- Minesh P MehtaNRG Oncology
- Intervention
- 3-Dimensional Conformal Radiation Therapy(radiation)
- Enrollment
- 606 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2026
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
- Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Arizona Oncology Associates-West Orange Grove, Tucson, Arizona, United States
- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield, California, United States
- Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States
- Eden Hospital Medical Center, Castro Valley, California, United States
- Fresno Cancer Center, Fresno, California, United States
- Marin General Hospital, Greenbrae, California, United States
- Loma Linda University Medical Center, Loma Linda, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02179086 on ClinicalTrials.govOther trials for Giant cell glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07544992Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade GliomasCity of Hope Medical Center
- RECRUITINGEARLY PHASE1NCT07268053A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain MetastasesNader Sanai
- RECRUITINGPHASE2NCT07511725Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk GlioblastomaSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE3NCT07195591Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareGT Medical Technologies, Inc.
- RECRUITINGPHASE2NCT07263438Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 TrialCentre Hospitalier Universitaire Vaudois
- RECRUITINGPHASE1NCT06176066PH Sensitive MRI Based Resections of GlioblastomaUniversity of California, Los Angeles
- RECRUITINGNANCT07121842Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRIErasmus Medical Center
- RECRUITINGNANCT06136611Preoperative Preradiotherapy TTFieldsThe Christie NHS Foundation Trust